Nicole Lambert - Oct 9, 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.
Signature
By: Nathan A. Smith For: Nicole Lambert
Stock symbol
MYGN
Transactions as of
Oct 9, 2021
Transactions value $
-$385,475
Form type
4
Date filed
10/12/2021, 04:46 PM
Previous filing
Oct 4, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability -$155K -5.01K -2.84% $30.88 172K Oct 9, 2021 Direct F1
transaction MYGN Common Stock Tax liability -$231K -7.47K -4.35% $30.88 164K Oct 9, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021.
F2 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021.

Remarks:

Ms. Lambert's title is Group President, Myriad Oncology, Myriad Women's Health and Myriad International.